PILOTTO, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 11.593
AS - Asia 4.404
EU - Europa 4.168
SA - Sud America 1.243
AF - Africa 192
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.634
Nazione #
US - Stati Uniti d'America 11.397
SG - Singapore 1.812
IT - Italia 1.712
BR - Brasile 975
CN - Cina 858
HK - Hong Kong 565
SE - Svezia 387
RU - Federazione Russa 354
FR - Francia 348
FI - Finlandia 327
VN - Vietnam 310
DE - Germania 300
BD - Bangladesh 203
GB - Regno Unito 192
UA - Ucraina 168
IN - India 134
NL - Olanda 100
ID - Indonesia 98
AR - Argentina 95
CA - Canada 94
IQ - Iraq 57
MX - Messico 56
TR - Turchia 52
PK - Pakistan 45
ZA - Sudafrica 43
ES - Italia 42
PL - Polonia 42
EC - Ecuador 40
MA - Marocco 40
AT - Austria 39
JP - Giappone 35
SA - Arabia Saudita 35
IE - Irlanda 33
VE - Venezuela 30
AU - Australia 28
BE - Belgio 28
CO - Colombia 27
CL - Cile 25
UZ - Uzbekistan 25
TN - Tunisia 21
KE - Kenya 19
PH - Filippine 19
PE - Perù 18
KR - Corea 15
MY - Malesia 15
PY - Paraguay 15
CI - Costa d'Avorio 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
NP - Nepal 12
ET - Etiopia 11
JO - Giordania 11
CR - Costa Rica 10
DZ - Algeria 10
EG - Egitto 10
JM - Giamaica 10
TH - Thailandia 10
BO - Bolivia 9
IL - Israele 9
IR - Iran 9
LT - Lituania 9
SN - Senegal 9
OM - Oman 8
PS - Palestinian Territory 8
TW - Taiwan 8
AZ - Azerbaigian 7
BG - Bulgaria 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
AL - Albania 6
RS - Serbia 6
CZ - Repubblica Ceca 5
KG - Kirghizistan 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
AO - Angola 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HR - Croazia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
EE - Estonia 3
GR - Grecia 3
LI - Liechtenstein 3
LY - Libia 3
NO - Norvegia 3
PA - Panama 3
QA - Qatar 3
BY - Bielorussia 2
CY - Cipro 2
DK - Danimarca 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
Totale 21.602
Città #
Fairfield 1.371
Ashburn 1.194
Singapore 964
Woodbridge 922
Houston 709
Chandler 659
San Jose 604
Seattle 593
Hong Kong 550
Cambridge 543
Milan 525
Wilmington 451
Ann Arbor 357
Jacksonville 346
Nyköping 341
Beijing 270
Dallas 237
Helsinki 229
Lauterbourg 174
New York 173
Rome 155
Lawrence 151
Roxbury 151
Los Angeles 137
Nanjing 114
Council Bluffs 113
Des Moines 108
Santa Clara 95
Boardman 92
Ho Chi Minh City 91
Bari 74
São Paulo 72
San Diego 71
Jakarta 68
Dearborn 67
Hanoi 64
Munich 58
Brooklyn 53
Dong Ket 53
Figino 48
Paris 48
Falkenstein 47
Chicago 46
Turin 44
London 43
Princeton 43
Buffalo 41
Rio de Janeiro 41
Inglewood 40
Columbus 39
Taranto 39
The Dalles 37
Nuremberg 33
Dublin 32
Washington 32
Moscow 31
Genoa 29
Ostuni 28
Tokyo 27
Redwood City 26
Warsaw 26
Brussels 25
Shenyang 25
Frankfurt am Main 23
Nanchang 23
Ruvo Di Puglia 22
Sydney 22
Toronto 22
Baghdad 21
Porto Alegre 21
Pune 21
Strasbourg 21
Atlanta 20
Belo Horizonte 20
Montreal 20
Naples 20
San Francisco 20
Tashkent 20
Jiaxing 19
Orem 18
Mexico City 17
Phoenix 17
Boston 16
Denver 16
Jeddah 16
Nairobi 16
Quito 16
Hebei 15
Johannesburg 15
Manchester 15
Amsterdam 14
Bologna 14
Guayaquil 14
Lahore 14
Las Vegas 14
Vienna 14
Abidjan 13
Brasília 13
Casablanca 13
Changsha 13
Totale 14.517
Nome #
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 511
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 252
Development of a smart post-hospitalization facility for older people by using domotics, robotics, and automated tele-monitoring 245
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 243
A multidimensional approach to frailty in older people 213
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 202
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 197
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 193
Validation of a Brief Form of the Self-Administered Multidimensional Prognostic Index: The SELFY-BRIEF-MPI Project 191
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 186
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 185
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 183
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 178
Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis 178
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 176
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 174
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 174
Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder 174
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 173
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 172
A New Computer-Based Tool to Reduce Potentially Inappropriate Prescriptions in Hospitalized Geriatric Patients 170
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 168
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 168
Paraplegia due to Anterior Spinal Artery Stroke: Rehabilitative Program on Lower Extremity Weakness and Locomotor Function 167
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 165
The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI) 163
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 162
Robotic balance assessment in community-dwelling older people with different grades of impairment of physical performance 162
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 160
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 158
. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging 151
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 150
Enteral tube feeding and mortality in hospitalized older patients: A multicenter longitudinal study 150
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 148
Frailty and the gut 148
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 148
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 148
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 148
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 146
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 144
Cognitive frailty: Predementia syndrome and vascular risk factors 143
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 142
Nutrition, frailty, and Alzheimer's disease. 142
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 142
Agreement of a short form of the self-administered multidimensional prognostic index (SELFY-MPI-SF): A useful tool for the self-assessment of frailty in community-dwelling older people 142
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 140
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 138
Using the Multidimensional Prognostic Index to Predict Clinical Outcomes of Hospitalized Older Persons: A Prospective, Multicenter, International Study 138
Vascular risk factors, alcohol intake, and cognitive decline 137
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 137
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 136
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 136
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 136
Validation of Abbreviated Form of the Multidimensional Prognostic Index (MPI): The BRIEF-MPI Project 135
Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies 135
The Multidimensional Prognostic Index Predicts in-hospital length of stay in older patients: A multicentre prospective study 135
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 133
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 132
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 131
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 131
Robot-based assessment of sitting and standing balance: Preliminary results in Parkinson's disease 131
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 130
A multidimensional approach to older patients during COVID-19 pandemic: a position paper of the Special Interest Group on Comprehensive Geriatric Assessment of the European Geriatric Medicine Society (EuGMS) 128
Dietary unsaturated fatty acids and risk of mild cognitive impairment 128
Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer's Disease 128
The prognostic significance of geriatric syndromes and resources 128
The multidimensional prognostic index (MPI) for the prognostic stratification of older inpatients with COVID-19: A multicenter prospective observational cohort study 127
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease 126
. Mediterranean diet in predementia and dementia syndromes.REview 125
Effects of oral amino acid supplementation on Multidimensional Prognostic Index in hospitalized older patients: a multicenter randomized, double-blind, placebo-controlled pilot study 125
Oral health indicators and bone mineral density disorders in older age: A systematic review 123
Management of beta-thalassemia-associated osteoporosis 123
The Multidimensional Prognostic Index in general practice: One-year follow-up study 122
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study 121
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. 120
Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 119
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. 118
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease 118
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 117
Current epidemiological approaches to the metabolic-cognitive syndrome. 117
Cerebral vasoreactivity and intima-media thickness in Down syndrome: A case-control study 116
Diet and Alzheimer's disease risk factors or prevention: the current evidence 115
Apolipoprotein E, dementia, and human longevity 115
Urological-Geriatric Integrated Diagnostic-Therapeutic Pathway for elderly patients with urologic diseases 115
Reply to Letter to the Editor “Polypharmacy in elderly people with diabetes admitted to hospital” 115
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients 114
APOE and Alzheimer disease: a major gene with semi-dominant inheritance 114
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia 114
Comprehensive Geriatric Assessment 113
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients 113
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 112
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease 111
Development and implementation of multicomponent homecare interventions for multimorbid and frail older people based on Information and Communication Technologies: The MULTIPLAT_AGE project 111
Dietary patterns and protection against Alzheimer disease and cognitive decline 110
Different models of frailty in predementia and dementia syndromes. 110
Mediterranean diet in predementia and dementia syndromes 109
Baseline Frailty Evaluation in Drug Development 109
Evaluation design of effichronic: The chronic disease self-management programme (CDSMP) intervention for citizens with a low socioeconomic position 108
Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project 108
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 107
Totale 14.778
Categoria #
all - tutte 84.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.026 46 65 7 29 60 107 50 46 78 78 164 296
2022/20231.805 246 172 126 157 170 232 33 246 287 22 76 38
2023/2024703 57 105 53 49 54 173 27 46 21 33 17 68
2024/20253.291 83 57 262 142 91 248 357 260 177 201 488 925
2025/20268.184 956 346 546 815 768 517 990 322 806 710 387 1.021
2026/2027157 157 0 0 0 0 0 0 0 0 0 0 0
Totale 22.193